| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $6.04 ▼ -3.05% | Yesterday | $5.92 ▲ +5.24% | Tomorrow's Xeris Biopharma Holdings Inc. Common Stock (XERS) setup is anchored to $6.23 and targets $6.04 (-3.05%). The near-term read is downside; watch $7.01 / $6.11 because daily realized volatility is about 2.77%. |
Tomorrow's Xeris Biopharma Holdings Inc. Common Stock (XERS) setup is anchored to $6.23 and targets $6.04 (-3.05%). The near-term read is downside; watch $7.01 / $6.11 because daily realized volatility is about 2.77%. | ||||
| Week | $6.21 ▼ -0.32% | Last Week | $6.38 ▼ -2.35% | The 7-day Xeris Biopharma Holdings Inc. Common Stock model moves from $6.38 to $6.21 (-0.32%). It gives downside momentum context for this stock, so breaks around $7.01 / $6.11 matter more than a single tick. |
The 7-day Xeris Biopharma Holdings Inc. Common Stock model moves from $6.38 to $6.21 (-0.32%). It gives downside momentum context for this stock, so breaks around $7.01 / $6.11 matter more than a single tick. | ||||
| Month | $6.57 ▲ +5.46% | Last Month | $5.89 ▲ +5.77% | The 1-month Xeris Biopharma Holdings Inc. Common Stock target is $6.57 (+5.46%), compared with the live reference near $6.23. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Xeris Biopharma Holdings Inc. Common Stock target is $6.57 (+5.46%), compared with the live reference near $6.23. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $7.07 ▲ +13.48% | Last Year | $4.92 ▲ +26.63% | The 1-year Xeris Biopharma Holdings Inc. Common Stock scenario points to $7.07 (+13.48%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Xeris Biopharma Holdings Inc. Common Stock scenario points to $7.07 (+13.48%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $8.19 ▲ +31.46% | 5 Years Ago | $3.47 ▲ +79.54% | The 5-year Xeris Biopharma Holdings Inc. Common Stock view is $8.19 (+31.46%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Xeris Biopharma Holdings Inc. Common Stock view is $8.19 (+31.46%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 65.6 | Bullish |
| MACD | -0.07 | Bearish |
| SMA 50 | $6.23 | Mid |
| SMA 200 | $5.74 | Mid |
| EMA 20 | $5.72 | Mid |
| Opening Price | $5.93 | Start Date | 2020-01-02 |
| Day Range | $5.91 – $6.25 | Market Cap | $1.02B |
| Monthly Range | $5.85 – $6.63 | 24h Volume | n/a |
| 90D Range | $5.29 – $7.87 | Circulating | n/a |
| 52W Range | $3.20 – $9.90 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.